GlassScriptPhysician profile
Vincent J Pongia
NPI 1689687204
$3,360.17
in general payments reported to CMS, 2019-2025
45 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $210 · 2021: $241 · 2022: $642 · 2023: $746 · 2024: $906 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,868.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $424.96 | 2019-2024 | Nuzyra |
| Convatec INC. | $406.60 | 2023-2025 | |
| Smith+Nephew, INC. | $379.86 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home, Stravix Pl |
| Bioventus LLC | $193.77 | 2022-2023 | Theragenesis Bilayer Wound Matrix |
| Aroa Biosurgery Incorporated | $163.55 | 2022 | |
| Abbvie INC. | $162.27 | 2021-2024 | |
| Grt US Holding, INC. | $128.85 | 2021-2022 | |
| Horizon Therapeutics Plc | $120.50 | 2019-2022 | |
| Nevro Corp. | $115.14 | 2022-2024 | Senza |
| Tactile Systems Technology INC | $106.24 | 2020-2023 | Entre Plus, Flexitouch Plus |
| Organogenesis INC. | $92.46 | 2022-2025 | Cygnus Dual, Via Matrix |
| Averitas Pharma INC. | $83.81 | 2023-2025 | Qutenza |
| Reapplix INC. | $79.34 | 2021-2023 | 3c Patch Kit - Box |
| Osiris Therapeutics INC. | $64.61 | 2019 | |
| Lifenet Health | $54.99 | 2023-2024 | Theragenesis Wound Matrix |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $50.28 | 2024 | Promogran Prisma, V.A.C. Dermatac, Activ.A.C. |
| Orthofix Medical, INC. | $49.03 | 2024-2025 | Physio-Stim |
| Ibsa Pharma INC. | $48.83 | 2023-2024 | Licart, Tirosint, Tirosint |
| Nabriva Therapeutics, Plc | $44.83 | 2021-2022 | |
| Melinta Therapeutics, LLC | $42.74 | 2019 | |
| Hartmann USA, INC. | $42.03 | 2024-2025 | Zetuvit Plus 10x10 P10 |
| Merck Sharp & Dohme LLC | $32.83 | 2019 | |
| Kci USA, INC. | $31.91 | 2021-2022 | |
| Stryker Corporation | $30.86 | 2019 | |
| Allergan, INC. | $30.78 | 2019-2020 | |
| Urgo Medical North America, LLC | $30.52 | 2024 | Urgok2 |
| Sanara Medtech INC. | $30.09 | 2024 | Celleraterx |
| Reddress USA, INC. | $29.33 | 2021-2023 | |
| Misonix INC | $23.97 | 2021 | |
| Davol INC. | $22.76 | 2020 | |
| Amgen INC. | $21.57 | 2024 | Krystexxa |
| Progenacare Global, LLC | $20.45 | 2024 | |
| Zimmer Biomet Holdings, INC. | $19.24 | 2021 | |
| Highridge Medical LLC | $19.08 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Paladin Technology Solutions | $18.65 | 2024 | |
| Boston Scientific Corporation | $18.51 | 2024 | Wavewriter Alpha Prime 16 |
| Musculoskeletal Transplant Foundation INC. | $16.96 | 2022 | |
| Paragon 28, INC. | $16.65 | 2025 | Precision Guide Lapidus |
| Vertex Pharmaceuticals Incorporated | $16.13 | 2025 | |
| Arthrosurface Incorporated | $15.33 | 2019 | |
| Ermi LLC | $14.35 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.27 | 2022 | |
| Zyla Life Sciences, INC. | $11.07 | 2020 | |
| Integra Lifesciences Corporation | $10.91 | 2019 | |
| Cashflow Solutions, LLC | $9.26 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Pongia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.